MRA Associates USA LLC purchased a new position in shares of SenesTech Inc (NASDAQ:SNES) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 25,281 shares of the company’s stock, valued at approximately $46,000. MRA Associates USA LLC owned 0.09% of SenesTech as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in the stock. First Interstate Bank bought a new position in SenesTech during the second quarter worth about $31,000. Virtu Financial LLC increased its position in SenesTech by 87.4% during the first quarter. Virtu Financial LLC now owns 56,447 shares of the company’s stock worth $69,000 after acquiring an additional 26,322 shares during the period. Finally, Meitav Dash Investments Ltd. bought a new position in SenesTech during the first quarter worth about $81,000. 7.00% of the stock is currently owned by institutional investors and hedge funds.
Separately, ValuEngine raised shares of SenesTech from a “hold” rating to a “buy” rating in a research report on Friday, June 28th.
NASDAQ:SNES traded up $0.17 during mid-day trading on Friday, reaching $1.17. 17,476 shares of the company’s stock were exchanged, compared to its average volume of 190,656. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.60 and a current ratio of 3.73. SenesTech Inc has a one year low of $0.55 and a one year high of $1.95. The firm has a market capitalization of $35.92 million, a PE ratio of -1.86 and a beta of 1.76. The business’s fifty day simple moving average is $1.43 and its two-hundred day simple moving average is $1.35.
SenesTech (NASDAQ:SNES) last released its earnings results on Tuesday, August 13th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.01. SenesTech had a negative net margin of 3,432.63% and a negative return on equity of 169.12%. The firm had revenue of $0.02 million for the quarter.
In other SenesTech news, insider Cheryl Ann Dyer sold 40,000 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1.19, for a total value of $47,600.00. Following the transaction, the insider now directly owns 391,165 shares of the company’s stock, valued at approximately $465,486.35. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kenneth S. Siegel bought 696,296 shares of the firm’s stock in a transaction on Tuesday, July 16th. The stock was purchased at an average cost of $1.35 per share, for a total transaction of $939,999.60. Following the completion of the acquisition, the chief executive officer now owns 702,558 shares in the company, valued at $948,453.30. The disclosure for this purchase can be found here. 10.91% of the stock is owned by company insiders.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Further Reading: Options Trading – Understanding Strike Price
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.